PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY TECHNOLOGY • Market segmentation by technology PART 07: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • Consumables - Market size and forecast 2018-2023 • Equipment - Market size and forecast 2018-2023 • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user PART 10: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 13: MARKET TRENDS • Advances in NGS techniques • Reduced costs of gene sequencing • Developments in the field of bioinformatics and cloud-based software • programs PART 14: VENDOR LANDSCAPE • Overview • Landscape disruption PART 15: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bio-Rad Laboratories Inc. • Eurofins GSC Lux Sarl • F. Hoffmann-La Roche Ltd. • Illumina Inc. • Invitae Corp. • Laboratory Corp. of America Holdings • Merck KGaA • PerkinElmer Inc. • QIAGEN Group • Thermo Fisher Scientific Inc. PART 16: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 17: EXPLORE TECHNAVIO Exhibit 01: Vendor offering overview Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: Consumables - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Consumables - Year-over-year growth 2019-2023 (%) Exhibit 22: Equipment - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Equipment - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by end-user 2018 (%) Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 46: Bio-Rad Laboratories Inc. - Business segments Exhibit 47: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 48: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 49: Bio-Rad Laboratories Inc. - Segment focus Exhibit 50: Bio-Rad Laboratories Inc. - Key offerings Exhibit 51: Eurofins GSC Lux Sarl - Vendor overview Exhibit 52: Eurofins GSC Lux Sarl - Business segments Exhibit 53: Eurofins GSC Lux Sarl - Organizational developments Exhibit 54: Eurofins GSC Lux Sarl - Geographic focus Exhibit 55: Eurofins GSC Lux Sarl - Segment focus Exhibit 56: Eurofins GSC Lux Sarl - Key offerings Exhibit 57: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 58: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 59: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 60: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 61: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 62: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 63: Illumina Inc. - Vendor overview Exhibit 64: Illumina Inc. - Business segments Exhibit 65: Illumina Inc. - Organizational developments Exhibit 66: Illumina Inc. - Geographic focus Exhibit 67: Illumina Inc. - Segment focus Exhibit 68: Illumina Inc. - Key offerings Exhibit 69: Invitae Corp. - Vendor overview Exhibit 70: Invitae Corp. - Business segments Exhibit 71: Invitae Corp. - Organizational developments Exhibit 72: Invitae Corp. - Geographic focus Exhibit 73: Invitae Corp. - Key offerings Exhibit 74: Laboratory Corp. of America Holdings - Vendor overview Exhibit 75: Laboratory Corp. of America Holdings - Business segments Exhibit 76: Laboratory Corp. of America Holdings - Organizational developments Exhibit 77: Laboratory Corp. of America Holdings - Geographic focus Exhibit 78: Laboratory Corp. of America Holdings - Segment focus Exhibit 79: Laboratory Corp. of America Holdings - Key offerings Exhibit 80: Merck KGaA - Vendor overview Exhibit 81: Merck KGaA - Business segments Exhibit 82: Merck KGaA - Organizational developments Exhibit 83: Merck KGaA - Geographic focus Exhibit 84: Merck KGaA - Segment focus Exhibit 85: Merck KGaA - Key offerings Exhibit 86: PerkinElmer Inc. - Vendor overview Exhibit 87: PerkinElmer Inc. - Business segments Exhibit 88: PerkinElmer Inc. - Organizational developments Exhibit 89: PerkinElmer Inc. - Geographic focus Exhibit 90: PerkinElmer Inc. - Segment focus Exhibit 91: PerkinElmer Inc. - Key offerings Exhibit 92: QIAGEN Group - Vendor overview Exhibit 93: QIAGEN Group - Product segments Exhibit 94: QIAGEN Group - Organizational developments Exhibit 95: QIAGEN Group - Geographic focus Exhibit 96: QIAGEN Group - Segment focus Exhibit 97: QIAGEN Group - Key offerings Exhibit 98: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 99: Thermo Fisher Scientific Inc. - Business segments Exhibit 100: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 101: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 102: Thermo Fisher Scientific Inc. - Segment focus Exhibit 103: Thermo Fisher Scientific Inc. - Key offerings Exhibit 104: Validation techniques employed for market sizing Exhibit 105: Definition of market positioning of vendors

Bio-Rad Laboratories Inc., Eurofins GSC Lux Sarl, F. Hoffmann-La Roche Ltd., Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, Merck KGaA, PerkinElmer Inc., QIAGEN Group, and Thermo Fisher Scientific Inc.